leisure time -WSS

leisure time

author：fashion 2025-09-06 01:57:38 - browse：891

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The high cost of giving birth even with insurance
Next article： SCOTUS questions limit to govt efforts to fight misinformation

leisure time

WSS

House passes resolution saying Israel isn't a 'racist or apartheid state'

Readout Newsletter: Bluebird, CVS, Contineum

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Baby aspirin cuts fat buildup in liver disease patients, in small study

Asbestos, a deadly carcinogen, banned by EPA

Baby aspirin cuts fat buildup in liver disease patients, in small study

hotspot

leisure time

knowledge

George Santos makes 1st court appearance after pleading not guilty to 13 counts

15 die by electrocution after transformer explodes in northern India

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Asbestos, a deadly carcinogen, banned by EPA

The high cost of giving birth even with insurance

Positive childhood experiences can help future health

At least 13 dead in Texas as scorching temps continue

Health AI adoption puts security, privacy startups on investors' radar

United colonoscopy coverage change 'may cost lives,' doctors say

A look at other Americans who have crossed into North Korea over the years

leisure time

Baby aspirin cuts fat buildup in liver disease patients, in small study

BridgeBio heart drug succeeds in pivotal study

Health AI adoption puts security, privacy startups on investors' radar

Methadone treatment changes are coming. Do they go far enough?

Why you get paid to donate plasma but not blood

Why you get paid to donate plasma but not blood

leisure time

focus

focus

entertainment